Literature DB >> 18760282

A simple high-throughput purification method for hit identification in protein screening.

Emma Cummins1, Deborah P Luxenberg, Fionnuala McAleese, Angela Widom, Brian J Fennell, Alfredo Darmanin-Sheehan, Matthew J Whitters, Laird Bloom, Davinder Gill, Orla Cunningham.   

Abstract

Phage and ribosome display technologies have emerged as important tools in the high-throughput screening of protein pharmaceuticals. However, a challenge created by the implementation of such tools is the need to purify large numbers of proteins for screening. While some assays may be compatible with crude bacterial lysates or periplasmic extracts, many functional assays, particularly cell-based assays, require protein of high purity and concentration. Here we evaluate several methods for small-scale, high-throughput protein purification. From our initial assessment we identified the HIS-Select 96-well filter plate system as the method of choice for further evaluation. This method was optimized and used to produce scFvs that were tested in cell-based functional assays. The behavior of HIS-Select purified scFvs in these assays was found to be similar to scFvs purified using a traditional large-scale 2-step purification method. The HIS-Select method allows high-throughput purification of hundreds of scFvs with yields in the 50-100 microg range, and of sufficient purity to allow evaluation in a cell-based proliferation assay. In addition, the use of a similar 96-well-based method facilitates the purification and subsequent screening of large numbers of IgGs and Fc fusion proteins generated through reformatting of scFv fragments.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18760282     DOI: 10.1016/j.jim.2008.07.016

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  8 in total

1.  Improving the pharmacokinetic properties of biologics by fusion to an anti-HSA shark VNAR domain.

Authors:  Mischa R Müller; Kenneth Saunders; Christopher Grace; Macy Jin; Nicole Piche-Nicholas; John Steven; Ronan O'Dwyer; Leeying Wu; Lam Khetemenee; Yulia Vugmeyster; Timothy P Hickling; Lioudmila Tchistiakova; Stephane Olland; Davinder Gill; Allan Jensen; Caroline J Barelle
Journal:  MAbs       Date:  2012 Nov-Dec       Impact factor: 5.857

2.  In vitro potency, pharmacokinetic profiles, and pharmacological activity of optimized anti-IL-21R antibodies in a mouse model of lupus.

Authors:  Yulia Vugmeyster; Heath Guay; Pamela Szklut; Ming D Qian; Macy Jin; Angela Widom; Vikki Spaulding; Frann Bennett; Leslie Lowe; Tatyana Andreyeva; David Lowe; Steven Lane; George Thom; Viia Valge-Archer; Davinder Gill; Deborah Young; Laird Bloom
Journal:  MAbs       Date:  2010-05-23       Impact factor: 5.857

3.  An ultra-specific avian antibody to phosphorylated tau protein reveals a unique mechanism for phosphoepitope recognition.

Authors:  Heather H Shih; Chao Tu; Wei Cao; Anne Klein; Renee Ramsey; Brian J Fennell; Matthew Lambert; Deirdre Ní Shúilleabháin; Bénédicte Autin; Eugenia Kouranova; Sri Laxmanan; Steven Braithwaite; Leeying Wu; Mostafa Ait-Zahra; Anthony J Milici; Jo Ann Dumin; Edward R LaVallie; Maya Arai; Christopher Corcoran; Janet E Paulsen; Davinder Gill; Orla Cunningham; Joel Bard; Lydia Mosyak; William J J Finlay
Journal:  J Biol Chem       Date:  2012-11-12       Impact factor: 5.157

4.  A multi-column plate adapter provides an economical and versatile high-throughput protein purification system.

Authors:  Matthew J Dominguez; Benjamin J Lantz; Rebecca J Rhode; Zoey L Sharp; Krysten C Finney; Valeria Jaramillo Martinez; Elliott J Stollar
Journal:  Protein Expr Purif       Date:  2018-07-21       Impact factor: 1.650

5.  CDR-restricted engineering of native human scFvs creates highly stable and soluble bifunctional antibodies for subcutaneous delivery.

Authors:  Brian J Fennell; Barry McDonnell; Amy Sze Pui Tam; Lijun Chang; John Steven; Ian D Broadbent; Huilan Gao; Elizabeth Kieras; Jennifer Alley; Deborah Luxenberg; Jason Edmonds; Lori J Fitz; Wenyan Miao; Matthew J Whitters; Quintus G Medley; Yongjing J Guo; Alfredo Darmanin-Sheehan; Bénédicte Autin; Deirdre Ní Shúilleabháin; Emma Cummins; Amy King; Mark R H Krebs; Christopher Grace; Timothy P Hickling; Angela Boisvert; Xiaotian Zhong; Matthew McKenna; Christopher Francis; Stephane Olland; Laird Bloom; Janet Paulsen; Will Somers; Allan Jensen; Laura Lin; William J J Finlay; Orla Cunningham
Journal:  MAbs       Date:  2013-08-21       Impact factor: 5.857

6.  Application of the Protein Maker as a platform purification system for therapeutic antibody research and development.

Authors:  Geneviève Hélie; Marie Parat; Frédéric Massé; Cory J Gerdts; Thomas P Loisel; Allan Matte
Journal:  Comput Struct Biotechnol J       Date:  2016-06-16       Impact factor: 7.271

7.  An Economical and Versatile High-Throughput Protein Purification System Using a Multi-Column Plate Adapter.

Authors:  Florence B Kineavy; Alex A Davies; Molly R Mitchell; Daniel Lay; Matt J Dominguez; Elliott J Stollar
Journal:  J Vis Exp       Date:  2021-05-21       Impact factor: 1.355

8.  In Vitro Maturation of a Humanized Shark VNAR Domain to Improve Its Biophysical Properties to Facilitate Clinical Development.

Authors:  John Steven; Mischa R Müller; Miguel F Carvalho; Obinna C Ubah; Marina Kovaleva; Gerard Donohoe; Thomas Baddeley; Dawn Cornock; Kenneth Saunders; Andrew J Porter; Caroline Jane Barelle
Journal:  Front Immunol       Date:  2017-10-23       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.